Austedo, a prescription medication developed and marketed by Teva Pharmaceuticals, plays a significant role in managing
Austedo Teva: Understanding This Medication and Its Manufacturer
Austedo, a prescription medication developed and marketed by Teva Pharmaceuticals, plays a significant role in managing specific neurological conditions. This article provides an overview of Austedo, its primary uses, and the connection to its manufacturer, Teva.
What is Austedo?
Austedo is the brand name for deutetrabenazine, a medication approved by regulatory bodies for treating certain involuntary movement disorders. It is not an antipsychotic but works differently to help reduce uncontrolled movements. As a prescription drug, Austedo must always be taken under the guidance and supervision of a qualified healthcare professional.
Conditions Treated by Austedo
Austedo is specifically indicated for two main neurological conditions:
- Chorea associated with Huntington's disease: Huntington's disease is a progressive neurodegenerative disorder that can cause involuntary, jerky movements known as chorea. Austedo is designed to help reduce the severity of these choreic movements.
- Tardive Dyskinesia (TD): Tardive dyskinesia is a neurological disorder characterized by repetitive, involuntary movements, often of the face, tongue, lips, or limbs. It can sometimes occur as a side effect of long-term use of certain medications, particularly older antipsychotics. Austedo offers a treatment option to help manage the symptoms of TD.
Teva Pharmaceuticals: The Manufacturer
Teva Pharmaceuticals, a global pharmaceutical company, is responsible for the development, manufacturing, and distribution of Austedo. With a strong focus on neuroscience, Teva has invested in research and development to bring innovative treatments to patients suffering from neurological and psychiatric disorders. Their commitment involves not only creating new medications but also ensuring their availability and providing support for patients and healthcare providers.
How Austedo Works
Austedo works by targeting and inhibiting a protein in the brain called vesicular monoamine transporter 2 (VMAT2). By reducing the activity of VMAT2, Austedo helps to decrease the amount of certain neurotransmitters, such as dopamine, that are released into the synapse. In conditions like Huntington's chorea and tardive dyskinesia, an imbalance or overactivity in these neurotransmitters can contribute to the involuntary movements. By modulating this system, Austedo aims to help restore a more balanced environment, thereby reducing the frequency and severity of these movements.
Important Considerations for Austedo
As a powerful prescription medication, Austedo has specific guidelines for its use. It is crucial for individuals considering or taking Austedo to have a thorough discussion with their doctor about their medical history, current medications, potential side effects, and any other concerns. A healthcare professional is best equipped to determine if Austedo is an appropriate treatment option and to monitor its effects.
This information is intended for general understanding and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis, treatment, and all medical decisions.